Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue The Lancet Neurology Année : 2010

Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition.

(1, 2, 3) , (4) , (1, 2, 3)
1
2
3
4

Résumé

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a chronic neuropathy of supposed immune origin. Understanding of its pathophysiology has recently improved, although its causes remain unclear. The classic presentation of CIDP includes sensory and motor symptoms in the distal and proximal segments of the four limbs with areflexia, evolving over more than 8 weeks. Raised protein concentrations in CSF and heterogeneous slowing of nerve conduction are typical of the condition. In addition to this usual phenotype, distribution of symptoms, disease course, and disability can be heterogeneous, leading to underdiagnosis of the disorder. Diagnosis is sometimes challenging and can require use of imaging and nerve biopsy. Steroids and intravenous immunoglobulin are effective, and plasma exchange can be helpful as rescue therapy. The usefulness of immunosuppressants needs to be established. The identification of specific diagnostic markers and new therapeutic strategies with conventional or targeted immunotherapy are needed to improve the outlook for patients with CIDP.
Fichier non déposé

Dates et versions

hal-00629750 , version 1 (06-10-2011)

Identifiants

Citer

Jean-Michel Vallat, Claudia Sommer, Laurent Magy. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition.. The Lancet Neurology, 2010, 9 (4), pp.402-12. ⟨10.1016/S1474-4422(10)70041-7⟩. ⟨hal-00629750⟩
54 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More